Over a month ago |
Conference/Events
|
Meetings to be held in… Meetings to be held in New York on April 4-5 hosted by William Blair. ShowHide Related Items >><< ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
ARCT Arcturus Therapeutics - 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
- 03/28/23
- Fly Intel: After-Hours Movers
- 11/04/22
- Biotech Alert: Searches spiking for these stocks today
|
Conference/Events
|
Meetings to be held in… Meetings to be held in New York on April 4-5 hosted by William Blair. ShowHide Related Items >><< ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
ARCT Arcturus Therapeutics - 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
- 03/28/23
- Fly Intel: After-Hours Movers
- 11/04/22
- Biotech Alert: Searches spiking for these stocks today
|
Conference/Events
|
Meetings to be held in… Meetings to be held in New York on April 4-5 hosted by William Blair. ShowHide Related Items >><< ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
ARCT Arcturus Therapeutics - 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
- 03/28/23
- Fly Intel: After-Hours Movers
- 11/04/22
- Biotech Alert: Searches spiking for these stocks today
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
EBS Emergent BioSolutions - 03/29/23
- Emergent says over-the-counter Narcan will be available by late summer
- 03/29/23
- Emergent BioSolutions: FDA approves OTC designation for Narcan Nasal Spray
- 03/29/23
- Emergent BioSolutions rises 17.5%
- 03/29/23
- Emergent jumps 19% to $10.60 after FDA approves over-the-counter Narcan
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
EBS Emergent BioSolutions - 03/17/23 JPMorgan
- Emergent BioSolutions downgraded to Underweight from Neutral at JPMorgan
- 12/28/22 Benchmark
- Benchmark keeps Hold on Emergent after non-profit OTC naloxone competitor news
- 11/10/22 Benchmark
- Benchmark downgrades Emergent on delay in smallpox vaccine fulfillment
- 11/10/22 Benchmark
- Emergent BioSolutions downgraded to Hold from Buy at Benchmark
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/29/23 Raymond James
- Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
EBS Emergent BioSolutions - 02/27/23
- Emergent BioSolutions sees FY23 revenue $1.1B-$1.2B, consensus $1.18B
- 02/27/23
- Emergent BioSolutions sees Q1 revenue $130M-$150M, consensus $245.9M
- 02/27/23
- Emergent BioSolutions reports Q4 EPS (31c), consensus 4c
- 01/09/23
- Emergent reports preliminary FY22 revenue $1.1B-$1.12B, consensus $1.09B
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
- $13.40 /
+2.165 (+19.27%) - 03/29/23
- Enovix announces manufacturing partner, location for Fab-2 in Malaysia
- 03/20/23
- Enovix director buys $757K in common stock
- 03/15/23
- Enovix director buys $1.35M in common stock
- 03/13/23
- Enovix announces several leadership additions
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
- $13.40 /
+2.165 (+19.27%) - 02/23/23 Craig-Hallum
- Enovix price target lowered to $15 from $23 at Craig-Hallum
- 02/23/23 Piper Sandler
- Enovix price target raised to $25 from $22.50 at Piper Sandler
- 01/26/23 JPMorgan
- Enovix price target lowered to $16 from $28 at JPMorgan
- 01/23/23 Piper Sandler
- Enovix price target lowered to $22.50 from $26.50 at Piper Sandler
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 09/27/22 Morgan Stanley
- Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- $13.40 /
+2.165 (+19.27%) - 02/22/23
- Enovix reports Q EPS (19c), consensus (16c)
- 11/01/22
- Enovix sees 2022 revenue $6M-$8M, consensus $6.62M
- 11/01/22
- Enovix reports Q3 EPS (53c), consensus (16c)
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|
Hot Stocks
|
In its Q4 results last… In its Q4 results last night, Arcturus Therapeutics stated: "The Company's cash balance totaled $391.9 million at December 31, 2022, compared to a cash balance of $370.5 million at December 31, 2021. In March 2023, the Company repaid Singapore $17.1 million which triggered the elimination of $33.3 million in non-recourse debt pertaining to the ARCT-021 program." Andrew Sassine, CFO of Arcturus Therapeutics, also noted: "Within the first four months of our CSL collaboration, we successfully achieved multiple program objectives, triggering $90 million in milestone payments. Additionally, with the elimination of $33.3 million of non-recourse debt to Singapore, our cash runway now extends into the beginning of 2026." ShowHide Related Items >><< ARCT Arcturus Therapeutics - 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 11/01/22
- CSL unit enters license agreement with Arcturus Therapeutics
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
ARCT Arcturus Therapeutics - 03/28/23
- Fly Intel: After-Hours Movers
- 11/04/22
- Biotech Alert: Searches spiking for these stocks today
- 11/02/22
- What You Missed On Wall Street On Wednesday
- 11/02/22
- What You Missed On Wall Street This Morning
|